Company Information

CIN
Status
Date of Incorporation
10 May 2013
State / ROC
Bangalore / ROC Bangalore
Last Balance Sheet
31 March 2023
Last Annual Meeting
29 September 2023
Paid Up Capital
100,000
Authorised Capital
1,000,000

Directors

Kunal Ashok Kashyap
Kunal Ashok Kashyap
Director/Designated Partner
over 2 years ago
Devi Prasad Shetty
Devi Prasad Shetty
Director/Designated Partner
over 2 years ago
Kiran Mazumdar Shaw
Kiran Mazumdar Shaw
Director/Designated Partner
over 2 years ago
John Mccallum Marshall Shaw
John Mccallum Marshall Shaw
Beneficial Owner
about 11 years ago

Past Directors

Paul Christadas Salins
Paul Christadas Salins
Additional Director
almost 12 years ago

Patents

Nanoparticle Based Drug Delivery System To Target Cancer Cells

ABSTRACT The present invention is in the technical field of nanoparticle delivery system, in particular, a self-assembling reconstituted high density lipoprotein complex comprising a combination of: a pH-specific polymer, a cross linker, a receptor binding component (R), and a drug (D); wherein the pH-specific po...

A Pharmaceutical Formulation Comprising Curcumin And Metformin For Head And Neck Cancer

ABSTRACT The present disclosure relates to cancer therapeutics, in particular, the invention relates to the use of Curcumin and Metformin in chemoprevention of cancers, including head and neck cancers. The use of this said combination of drugs in a pre-clinical carcinogenesis model has resulted in lower number of...

Anti Cxcr4 Inhibitor In Reversing Resistance To Chemoprevention And Chemotherapy

CXCR4 INHIBITOR IN REVERSING RESISTANCE TO CHEMOPREVENTION AND CHEMOTHERAPY ABSTRACT The present disclosure deals with compounds, compositions, methods to prevent, inhibit and/or treat cancer, and methods to promote Cancer Stem Cell (CSC). In particular, the invention relates to, CXCR4 inhibitor AMD in reversin...

Nanoparticle Based Biosensor For Cell Detection And Isolation

The present disclosure relates to a nanoparticle based biosensor for cell detection and isolation system, more particularly to isolate selective cell types possessing specific surface receptors from a heterogeneous cell population consisting of varied cell types bearing wide array of receptors. Furthermore, inventio...

Salivary Protein Biomarkers For The Diagnosis And Prognosis Of Head And Neck Cancers

ABSTRACT SALIVARY PROTEIN BIOMARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF HEAD AND NECK CANCERS, AND PRECANCERS The present disclosure relates to a panel of biomarkers for the detection/diagnosis and prognosis of head and neck squamous cell carcinoma (HNSCC). Biomarkers for the detection/diagnosis of carcinoma c...

Molecular Marker Based Oral Cytology For Detection Of Potentially Malignant And Malignant Oral Lesion

MOLECULAR MARKER BASED ORAL CYTOLOGY FOR DETECTION OF POTENTIALLY MALIGNANT AND MALIGNANT ORAL LESION ABSTRACT The present disclosure relates to a minimally invasive, molecular marker-based cytology method for the detection/diagnosis of oral potentially malignant (OPML) and malignant lesions. In particular, the ...

Systems And Methods For Analyzing Sequence Data

SYSTEMS AND METHODS FOR ANALYZING SEQUENCE DATA ABSTRACT The present invention relates to systems, methods, software and computer-usable media comprising a clustering tool for biomolecule-related sequence. Biomolecule-related sequences can relate to proteins, peptides, nucleic acids, and the like, and can incl...

Compositions And Methods For Treating Coronavirus Infection At Different Level Of Disease Severity

The present invention is in the technical field of a pharmaceutical composition comprising recombinant polypeptides; wherein the first recombinant polypeptide comprises a genetically modified ACE2 protein to increase binding to SARS-CoV and SARS-Cov2 viruses spike protein and neutralizing activity; and the second re...

Tumor Microenvironment Platform Comprising Oral Carcinoma For Predicting Drug Sensitivity, Drug Resistance And Disease Progression

The present disclosure relates to a tumor microenvironment platform comprising oral carcinoma for predicting drug sensitivity, drug resistance and disease progression. More particularly, invention focuses on a method for obtaining a tumor microenvironment platform comprising oral carcinoma for predicting chemoresist...

System And Method Comprising Expression Maps For Prognosticating Early Stage Oral Cancer

ABSTRACT SYSTEM AND METHOD COMPRISING EXPRESSION MAPS FOR PROGNOSTICATING EARLY-STAGE ORAL CANCER The disclosed embodiment relates to a system and method comprising expression maps for prognosticating early-stage oral cancer. More particularly, it involves the identification of specific CSC markers that are in spe...

3 D Model System For Tumour Microenvironment In Head And Neck Cancer

ABSTRACT 3D MODEL FOR TUMOUR MICROENVIRONMENT ANALYSIS The present disclosure relates to a system for 3D model for tumour microenvironment analysis. More particularly, the system is for analysis and prediction assay of clinical response for a subject upon targeting with radiotherapy and chemotherapy. Furthermore...

System For In Vitro Modelling Ofnodal Metastasis In Oral Squamous Cell Carcinoma

ABSTRACT SYSTEM FOR IN-VITRO MODELLING OF NODAL METASTASIS IN ORAL SQUAMOUS CELL CARCINOMA The present invention disclosure relates to a system for In-vitro modeling of nodal metastasis in oral squamous cell carcinoma. More particularly, the invention deals with the system and method for analysis and drug testin...

System Comprising Artificial Intelligence Integrated Molecular Cytology Andradiology For Triaging Of Thyroid Nodules

ABSTRACT SYSTEM COMPRISING ARTIFICIAL INTELLIGENCE INTEGRATED MOLECULAR CYTOLOGY AND RADIOLOGY FOR TRIAGING OF THYROID NODULES The disclosed embodiment relates to a composition and system comprising Artificial Intelligence integrated molecular cytology and radiology for triaging of thyroid nodules. More particular...

Registered Trademarks

Advanced Diagnostic Research Center Mazumdar Shaw Medical Foundation

[Class : 44] Medical Diagnostic Services, Medical Laboratory Services For The Analysis Of Samples Taken From Patients, Medical Analysis Services For Diagnostic And Treatment Purposes Provided By Medical Laboratories, Laboratory Analysis Services Relating To The Treatment Of Persons, Pathology Services Relating To The Treatment Of Persons

Documents

Form ADT-1-25112019_signed
List of share holders, debenture holders;-25112019
Form MGT-7-25112019_signed
Directors report as per section 134(3)-25112019
Copy of written consent given by auditor-25112019
Copy of the intimation sent by company-25112019
Copy of resolution passed by the company-25112019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-25112019
Form MGT-7-25112019
Form AOC-4-25112019_signed
Form ADT-1-30112018_signed
Copy of resolution passed by the company-30112018
List of share holders, debenture holders;-30112018
Directors report as per section 134(3)-30112018
Copy of written consent given by auditor-30112018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-30112018
Form AOC-4-30112018_signed
Form MGT-7-30112018_signed
Form ADT-1-10122017_signed
Form MGT-7-04122017_signed
Form AOC-4-02122017_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-29112017
List of share holders, debenture holders;-29112017
Copy of resolution passed by the company-28112017
Copy of the intimation sent by company-28112017
Copy of written consent given by auditor-28112017
Form ADT-1-24112016_signed
List of share holders, debenture holders;-23112016
Copy of the intimation sent by company-23112016
Copy of resolution passed by the company-23112016